<DOC>
	<DOCNO>NCT01655082</DOCNO>
	<brief_summary>The purpose study evaluate safety profile repeat application new transdermal patch compare reference product 3 week , large population .</brief_summary>
	<brief_title>Nicotine Patch Safety Study</brief_title>
	<detailed_description />
	<mesh_term>Nicotine</mesh_term>
	<criteria>Male female age 18 year Regular smoker motivate stop tobacco consumption Current smoker &gt; = 20 cigarettes/day &lt; = 25 cigarettes/day Fagerstr√∂m score &gt; = 5 ( smoker 10 20 cigarettes/day ) Any visible skin disorder , abnormal skin pigmentation dermatologic disease , opinion investigator would interfere assessment different parameter Current past serious chronic cardiovascular , renal , hepatic , gastrointestinal ( include duodenal gastric ulcer ) , endocrine , hematological , neuropsychiatric , immunosuppressive condition allergic disease , myopathy , epileptic seizure , bleed tendency , cancer History angina pectoris , myocardial infarction stroke previous 3 month , coronary artery vasospasm , cardiac arrhythmia , acute stroke Clinically relevant abnormal finding physical examination ( e.g large scar application zone )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Smoking cessation</keyword>
	<keyword>Nicotine</keyword>
	<keyword>Tobacco Use Disorder</keyword>
	<keyword>Central Nervous System Agents</keyword>
</DOC>